This is a working overview of somatotroph, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-20. Anything still debated is marked as such rather than presented as settled.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
reactive intermediate Also simply intermediate. Any short-lived, unstable, highly reactive chemical species which is generated briefly in a chemical reaction but rapidly undergoes further reactions that transform it into a more stable species. It is thus a transient intermediary between the stable reactants and products of the overall reaction. The existence of intermediates, when detectable, is critical to an accurate understanding of a reaction mechanism.
This fostered the amassing of enormous economic and political power by a few prominent industrialists, largely through the formation of trusts and monopolies to prevent competition. This resulted in significant increases in economic inequality, slum conditions, and civil unrest, creating a fertile environment for labor unions to flourish and, to a more limited extent, socialist movements to emerge. This period eventually ended with the advent of the Progressive Era, which was characterized by significant economic, legislative and social reforms. Pro-American elements in Hawaii overthrew the Hawaiian monarchy; the islands were annexed in 1898. That same year, Puerto Rico, the Philippines, and Guam were ceded to the U.S. by Spain after the latter's defeat in the Spanish–American War. (The Philippines was granted full independence from the U.S. on July 4, 1946, following World War II. Puerto Rico and Guam have remained U.S. territories.) American Samoa was acquired by the United States in 1900 after the Second Samoan Civil War. The U.S. Virgin Islands were purchased from Denmark in 1917 after Danish voters approved the sale in a 1916 referendum.
== In humans == There are many legends involving healing wounds by licking them or applying saliva. Saint Magdalena de Pazzi is said to have cured a nun of sores and scabs in 1589 by licking her limbs. The Roman Emperor Vespasian is said to have performed a healing of a blind man using his saliva. Pliny the Elder in his Natural History reported that a fasting woman's saliva is an effective cure for bloodshot eyes. In the Hebrew Bible saliva is associated with uncleanliness; however, in the Gospels there are three incidents where Jesus uses saliva to heal (Mark 7:33, Mark 8:23, John 9:6). Köstenberger suggests "by using saliva to cure a man, Jesus claims to possess unusual spiritual authority." There are potential health hazards in wound licking due to infection risk, especially in immunocompromised patients. Human saliva contains a wide variety of bacteria that are harmless in the mouth, but that may cause significant infection if introduced into a wound. A notable case was a diabetic man who licked his bleeding thumb following a minor bicycle accident, and subsequently had to have the thumb amputated after it became infected with Eikenella corrodens from his saliva.
== Tumor cells and haptotaxis == A characteristic of many cancers is the ability to move throughout the body. These are malignant cells, and pose a serious threat to the health of an individual. It has been indicated that haptotaxis plays a role in the ability of malignant cells to metastasize. One factor that was initially found to influence haptotaxis is serum spreading factor, which is present in blood serum and interstitial tissues. The presence of serum spreading factor was shown to influence directed migration along a gradient of substrate molecules in a few types of cancer cells. Another component important in the haptotaxis of tumor cells is MenaINV, which is an actin regulatory protein that becomes increasingly expressed in tumor cells. This actin regulatory protein binds to fibronectin receptors and aids in the haptotactic and chemotactic processes of tumor cells.
Sources: en.wikipedia.org
All triterpenoids are synthesized via the cyclization of the C30 isoprenoid chain, squalene. Eukaryotes use oxidosqualene cyclase and several other enzymes to create the tetracyclic skeleton found in steroids, a process that requires molecular oxygen. Bacteria use a similar enzyme (shc) to create the pentacyclic hopanoid precursor, diploptene; however, this biosynthesis does not require oxygen. It was recently discovered that tetrahymanol-producing bacteria form diploptene using shc then elongate the final cyclopentane into a fifth ring using tetrahymanol synthase (ths). It is unknown whether bacteria modify diploptene into other hopene molecules before creating tetrahymanol. It has also been found with a methylation at the C-3 site. Eukaryotes that live in anaerobic environments cannot synthesize their own sterols because of a lack of molecular oxygen. These organisms can gain sterols through predation. However, there can be times of sterol starvation. Tetrahymanol biosynthesis does not require oxygen, and can substitute readily for sterols. It is hypothesized that ciliates synthesize tetrahymanol in response to lack of oxygen and exogenous sterols. The gene for tetrahymanol synthase was found in the genomes of many genera of alpha-, delta-, and gammaproteobacteria, including Rhodopseudomonas, Bradyrhizobium and Methylomicrobium.
At the October 1907 meeting of the American Roentgen Ray Society, Rome Vernon Wagner, an X-ray tube manufacturer, reported that he had begun carrying a photographic plate in his pocket and developing it every evening. This allowed him to determine how much radiation he had been exposed to. This was the forerunner of the film dosimeter. His efforts came too late, as he had already developed cancer and died six months after the conference. In the 1920s, the physical chemist John Eggert (1891-1973) played a key role in the introduction of film dosimetry for routine personal monitoring. Since then, it has been successively improved and, in particular, the evaluation technique has been automated since the 1960s. At the same time, Hermann Joseph Muller (1890-1967) discovered mutations as genetic consequences of X-rays, for which he was awarded the Nobel Prize in 1946. At the same time, the roentgen (R) was introduced as a unit for quantitative measurement of radiation exposure. A dosimeter for film is divided into multiple segments, each containing a light- or radiation-sensitive film surrounded by layers of copper and lead with varying thickness. The degree of radiation penetration determines whether the segment is not blackened or blackened to varying degrees. The absorbed radiation effect during the measurement time is summed up, and the radiation dose can be determined from the blackening. Guidelines for evaluation exist, with those for Germany being published in 1994 and last updated on December 8, 2003.
==== Gel-based Proteomic Methods ==== Two-dimensional Polyacrylamide Electrophoresis (2D-PAGE) gels historically compared intensities from protease treated and untreated sample spots in order to identify possible candidate substrates. A more recent improvement of this technique, fluorescent 2D difference gel electrophoresis (2D-DIGE), attempts to control standardization between gels for relative quantification. Differentially labelling protease-treated and untreated samples with either Cy3 or Cy5, pooling said samples, and analyzing them together by 2D-PAGE allows substrate and cleavage products to be studied from the fluorescent gel. The spots corresponding to potentially substrate and cleavage products can be later elucidated using Mass Spectrometry or Edman Sequencing. The biggest drawbacks to using these techniques relate to the chemistry of the technique itself and its lack of sensitivity. As they rely on PAGE gels, extremely large, small, highly hydrophobic, acidic, or basic molecules will not be visualized.
== Proposed mechanisms == Researchers in the field do not agree on a theory for cold fusion. One proposal considers that hydrogen and its isotopes can be absorbed in certain solids, including palladium hydride, at high densities. This creates a high partial pressure, reducing the average separation of hydrogen isotopes. However, the reduction in separation is not enough to create the fusion rates claimed in the original experiment, by a factor of ten. It was also proposed that a higher density of hydrogen inside the palladium and a lower potential barrier could raise the possibility of fusion at lower temperatures than expected from a simple application of Coulomb's law. Electron screening of the positive hydrogen nuclei by the negative electrons in the palladium lattice was suggested to the 2004 DOE commission, but the panel found the theoretical explanations not convincing and inconsistent with current physics theories.
The Vasa is a Swedish 1628 ship found archaeologically and was very well preserved. Completely submerged for 333 years allowed for the wood to be completely waterlogged but pollution in the 20th century off of the city Stockholm was able to kill any microorganisms that would have feast on the wreck, like the shipworm. Vasa was sprayed with a PEG solution for 17 years followed by a period of drying which is ongoing.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.